Cancer Diagnostics Market Growth Factors, Trends and Forecast Report to 2025

San Francisco, 28 January 2019 –  “Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, [2018 - 2025]”

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

cancer diagnostics market

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Browse Research Report On Cancer Diagnostics Market : www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further Key Findings from the Study Suggest:
  • Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.
  • The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.
  • In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.
  • Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.
View more reports of this category by Grand View Research at www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the cancer diagnostics market by screening type, application, and region:

Cancer Diagnostics Screening Type Outlook (Revenue, USD Billion; 2014 - 2025)
  • Laboratory Tests
  • Genetic Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others (barium enema)
Cancer Diagnostics Application Outlook (Revenue, USD Billion; 2014 - 2025)
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others
Cancer Diagnostics Regional Outlook (Revenue, USD Billion; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Matcha Market Is Anticipated to Attain Around $5.07 Billion By 2025

Image
San Francisco, 29 April 2019 – “ Matcha Market Analysis By Grade (Ceremonial, Classic, Culinary), By Application (Regular Tea, Matcha Beverages, Food, Personal Care), By Region, And Segment Forecasts, [2018 - 2025] ” The global matcha market is expected to reach USD 5.07 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases has augmented the demand for healthy and nutrient-rich food & beverage alternatives. Anti-oxidant and vitamin-rich composition of matcha tea has fueled the product demand across the globe. Anti-oxidants, including epigallocatechin gallate (EGCG), prevent diseases such as cancer, Type-2 diabetes, cardiovascular problems. EGCG present in the product can repair DNA damage caused by UV radiation and controls the proliferation of cancerous cells. The product also has the potential to reduce stress and promotes a state of relaxation. L-theanine present in the product acts in a synergistic way to activa...
Read more

Levulinic acid Market Strategy, Distributors & Manufacturing Cost Analysis Till 2020

Image
Global  levulinic acid market  demand was 2,606.2 tons in 2013 and is projected to be 3,820 tons by 2020. The increasing application of levulinic acid, especially in pesticides, solvents, pharmaceuticals, and cosmetics industries are anticipated to boost growth in the coming years. Over the past few years, the chemical industry has continually been striving towards attaining a sustainable growth, with a focus on the development of renewable biotechnological and bio-based products. The production technology for bio-based levulinic acid has been simplified by dehydration of biomass or carbohydrates with acid. Levulinic acid is being increasingly used as a substitute to its synthetic counterparts in industrial usage. Levulinic acid market volume share by application, 2013 The global levulinic acid market is anticipated to reach USD 19.65 million revenue, with a growing CAGR of 4.8% by 2020. Increasing usage of the acid in niche applications including plastics, nyl...
Read more

Endoscopy Devices Market Chances To Reach $17.19 Billion By 2025

Image
  The global  endoscopes market  size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market. Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to...
Read more